Joaquim Mullol Selected Research

rupatadine

1/2020	Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis.
1/2019	Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis.
10/2016	Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
11/2013	Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joaquim Mullol Research Topics

Disease

50	Asthma (Bronchial Asthma) 06/2022 - 08/2004
44	Nasal Polyps (Nasal Polyp) 07/2022 - 05/2002
34	Rhinosinusitis 07/2022 - 11/2006
30	Allergic Rhinitis 10/2022 - 10/2004
17	Inflammation (Inflammations) 01/2022 - 05/2008
14	Hypersensitivity (Allergy) 10/2022 - 01/2012
12	Rhinitis 01/2020 - 10/2004
10	Polyps 01/2022 - 01/2003
7	COVID-19 01/2021 - 01/2020
5	Seasonal Allergic Rhinitis (Hay Fever) 03/2022 - 01/2012
5	Parkinson Disease (Parkinson's Disease) 10/2020 - 04/2011
5	Anosmia 01/2020 - 11/2009
4	Eosinophilia 01/2021 - 01/2014
4	Urticaria (Hives) 10/2016 - 01/2012
3	Rhinorrhea 01/2020 - 10/2004
3	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2019 - 05/2007
3	Aspirin-Induced Asthma 01/2019 - 01/2012
3	Nasal Obstruction 04/2017 - 03/2006
3	Neoplasms (Cancer) 10/2012 - 05/2008
2	Obesity 06/2022 - 04/2022
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 10/2021
2	Pathologic Processes 01/2021 - 05/2008
2	Headache (Headaches) 01/2021 - 02/2016
2	Nasopharyngitis 01/2021 - 02/2016
2	Prodromal Symptoms 12/2020 - 01/2018
2	Dyskinesias (Dyskinesia) 10/2020 - 10/2020
2	Perennial Allergic Rhinitis 01/2020 - 01/2012
2	Atopic Dermatitis (Atopic Eczema) 11/2019 - 02/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2019 - 01/2018
2	Disease Progression 01/2018 - 08/2003
2	Hyperplasia 01/2017 - 05/2015
2	Sinusitis 02/2016 - 06/2014
2	Sneezing 01/2012 - 10/2004
2	Pruritus (Itching) 01/2012 - 10/2004
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2011 - 03/2004
2	Idiopathic Pulmonary Fibrosis 03/2004 - 08/2003
1	Weight Loss (Weight Reduction) 06/2022
1	Bronchiectasis 01/2022

Drug/Important Bio-Agent (IBA)

15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 05/2002
14	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 11/2009
10	Pharmaceutical PreparationsIBA 10/2022 - 01/2012
9	dupilumabIBA 01/2022 - 02/2016
7	CytokinesIBA 06/2022 - 08/2003
7	GlucocorticoidsIBA 04/2022 - 08/2004
7	SteroidsIBA 01/2020 - 03/2006
6	AllergensIBA 01/2022 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 03/2021 - 05/2015
6	Immunoglobulin E (IgE)IBA 01/2021 - 06/2012
6	Messenger RNA (mRNA)IBA 10/2020 - 01/2003
6	Histamine Antagonists (Antihistamines)IBA 04/2017 - 02/2011
6	levocetirizine FDA LinkGeneric 11/2013 - 10/2004
4	azelastine (Optivar)FDA LinkGeneric 10/2022 - 11/2012
4	Fluticasone (Cutivate)FDA LinkGeneric 10/2022 - 11/2012
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 03/2011
4	InterleukinsIBA 02/2021 - 08/2004
4	rupatadineIBA 01/2020 - 11/2013
4	desloratadine (Aerius)FDA LinkGeneric 05/2013 - 01/2010
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2013 - 03/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012 - 05/2002
3	Omalizumab (Xolair)FDA Link 01/2022 - 09/2011
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022 - 02/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2021 - 02/2009
3	Platelet Activating FactorIBA 08/2019 - 03/2013
3	montelukast (Singulair)FDA Link 01/2019 - 05/2008
3	bilastineIBA 08/2013 - 01/2012
3	ProstaglandinsIBA 07/2011 - 05/2002
3	glucocorticoid receptor betaIBA 01/2009 - 01/2003
3	RNA (Ribonucleic Acid)IBA 08/2004 - 01/2003
3	Complementary DNA (cDNA)IBA 08/2004 - 01/2003
2	TabletsIBA 03/2022 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2020
2	Iron-Dextran Complex (InFed)FDA Link 01/2021 - 01/2018
2	Monoclonal AntibodiesIBA 01/2021 - 11/2019
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 08/2004
2	Interleukin-13IBA 01/2021 - 11/2019
2	Levodopa (L Dopa)FDA LinkGeneric 10/2020 - 10/2020
2	Oxidopamine (6 Hydroxydopamine)IBA 10/2020 - 04/2011
2	anti-IgE antibodiesIBA 01/2020 - 12/2019
2	SolutionsIBA 01/2019 - 11/2006
2	Nasal SpraysIBA 02/2016 - 11/2009
2	CollagenIBA 05/2015 - 10/2012
2	Matrix Metalloproteinases (MMPs)IBA 05/2015 - 05/2013
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2015 - 08/2004
2	Cetirizine (Zyrtec)FDA LinkGeneric 01/2012 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 12/2011 - 02/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2011 - 08/2004
2	Amphotericin B (Amphotericin)FDA LinkGeneric 02/2009 - 11/2006
2	Prednisone (Sone)FDA LinkGeneric 05/2006 - 03/2006
2	Protein Isoforms (Isoforms)IBA 08/2004 - 01/2003
1	mepolizumabIBA 07/2022
1	LeptinIBA 06/2022
1	AdiponectinIBA 06/2022
1	EicosanoidsIBA 11/2021

Therapy/Procedure

16	Therapeutics 01/2022 - 09/2004
4	Drug Therapy (Chemotherapy) 10/2022 - 08/2003
3	Self Medication 04/2019 - 01/2019
2	Biological Therapy 01/2022 - 12/2019
2	Aftercare (After-Treatment) 01/2020 - 01/2019
1	Bariatric Surgery 06/2022